Back to Carlyle Group Inc. Carlyle Group Inc.

QTTBQTTB

Showing 8 of 10 quarters

Position history for Carlyle Group Inc.Carlyle Group Inc.'s holdings in Q32 Bio Inc.

Yes. Carlyle Group holds 60,363 shares of QTTB (Q32 Bio), worth $769,020, as of its Q2 2026 13F filing. It reduced the position by 1,042,378 shares (-94.5%) from Q1 2026. Carlyle Group has held QTTB since Q1 2024, across 10 quarterly 13F filings.

Current Value

$769,020

Current Shares

60,363

Total Value Change

-$47.9M

Total Shares Change

-1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
60,363
-94.5%
$769,0200.0%$12.74
0
2026-Q1
Unchanged
1.1M
0.0%
$7.1M0.1%$4.89
0
2025-Q4
Unchanged
1.1M
0.0%
$3.6M0.0%$3.20
0
2025-Q3
Unchanged
1.1M
0.0%
$2.1M0.0%$1.94
0
2025-Q2
Unchanged
1.1M
0.0%
$1.6M0.0%$1.45
0
2025-Q1
Unchanged
1.1M
0.0%
$1.8M0.0%$1.71
0
2024-Q4
Unchanged
1.1M
0.0%
$3.8M0.1%$3.11
0
2024-Q3
Unchanged
1.1M
0.0%
$48.6M5.1%$46.00
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used